This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: Sab Biotherapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Christoph L Bausch: Innovator in Immunoglobulin Research
Introduction
Christoph L Bausch is a notable inventor based in Sioux Falls, SD (US). He has made significant contributions to the field of immunology, particularly in the development of treatments for coronavirus disease. His innovative work has led to the creation of valuable therapeutic products.
Latest Patents
Bausch holds a patent for "Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof." This patent provides human polyclonal immunoglobulin products aimed at treating or preventing coronavirus disease. The methods described in the patent involve creating such compositions in a transgenic ungulate, specifically utilizing a transchromosomic bovine (TcB) system.
Career Highlights
Christoph L Bausch is associated with Sab Biotherapeutics, Inc., where he continues to advance research in biotherapeutics. His work focuses on developing innovative solutions to combat viral infections, showcasing his commitment to improving public health.
Collaborations
Bausch collaborates with esteemed colleagues, including Eddie J Sullivan and Kristi A Egland. Their combined expertise enhances the research efforts at Sab Biotherapeutics, Inc., fostering an environment of innovation and discovery.
Conclusion
Christoph L Bausch is a pioneering inventor whose work in immunoglobulin research is making a significant impact in the fight against coronavirus disease. His contributions are vital to the advancement of therapeutic options in this critical area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile